Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +6.34% advanced 6.30% to $221.36 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.70% rising 0.79% to 14,253.27 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.36% rising 0.20% to 33,945.58. This was the stock's second consecutive day of gains. Moderna Inc. closed $6.35 below its 52-week high ($227.71), which the company reached on June 7th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.50% fell 0.03% to $114.70, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.18% fell 0.14% to $239.91, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -1.13% fell 0.72% to $57.89. Trading volume (10.0 M) eclipsed its 50-day average volume of 9.8 M.